To gain further insight into the prognostic value of the AP-2α/COX-2 signaling pathway in NPC patients, the levels of AP-2α and COX-2 proteins were tested and compared between the tumor tissue samples and the adjacent non-tumor tissue samples. This evidence concerns the gene PTGS2 and neoplasm.